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PREDICTORS OF HEALTH-RELATED 
QUALITY OF LIFE IN PATIENTS WITH 
LIVER CIRRHOSIS AT TERTIARY CARE 
HOSPITAL, KARACHI
Om Parkash, R Iqbal, I Azam, W Jafri
Section of Gastroenterology, Department of Medicine, 
Aga Khan University Hospital, Karachi, Pakistan
Introduction: Chronic liver disease/cirrhosis (CLD) in 
individuals produces a variety of symptoms which in turn 
lead to a negative impact on health-related quality of life 
(HRQOL). However, no such work has been carried out in 
Pakistan. The general aim of this study was to evaluate the 
magnitude of poor HRQOL and to assess factors related 
with HRQOL in patients with CLD.
Method: A cross-sectional study was conducted at the 
Gastroenterology Clinics of Aga Khan University Hospital. 
All adult patients diagnosed to have cirrhosis were in-
vited to participate. In this study, Chronic Liver Disease 
Questionnaire (CLDQ) was used to assess HRQOL of these 
patients. Patients were categorized into 2 groups based 
on CLDQ score; <5 as poor and ≥5 as good score for deter-
mination of the frequency of poor HRQOL. CLDQ score 
was used as an outcome measure to determine the factors 
related with HRQOL.
Result: Two-hundred and seventy-three participants were 
recruited; 155 (57%) were males. Mean age of participants 
was 49 years (SD ± 11 years). In this study, the most com-
mon cause for cirrhosis was viral infection 247 (91.5%). 
Mean Child Turcot Pugh (CTP) score was 8 ± 1.85 and the 
mean model for end stage liver disease (MELD) score was 
12.6 ± 6.8. Two-hundred and nine patients (76.6%) had CTP 
B or C class. Poor HRQOL was seen in 187 (69%) of the 
participants. Mean CLDQ score was 4.36 (SD ± 1.1). Among 
all of the domains, fatigue domain had significantly lower 
CLDQ score. On multivariable analysis, hemoglobin (β = 
0.09 [SE = 0.04]), albumin (β = 0.32 [SE = 0.09]), diastolic 
blood pressure (DBP) (β = 0.01 [0.005]), and prior history 
of decompensation (β = 0.98 [SE = 0.39] were the signifi-
cant factors associated with HRQOL in patients with liver 
cirrhosis.
Conclusion: Frequency of poor HRQOL determined 
by CLDQ score is high in patients with liver cirrhosis. 
Hemoglobin, serum albumen, diastolic blood pressure 
and prior history of decompensation are associated with 
HRQOL.
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25 GRAM VERSUS 50 GRAM OF 25% 
ALBUMIN IN PREVENTING RENAL 
IMPAIRMENT AFTER LARGE VOLUME 
PARACENTESIS IN CIRRHOSIS
AB Khalid, K Mumtaz, A Ghufran, Hasnain Alishah, 
S Hamid, W Jafri
Section of Gastroenterology, Department of Medicine, 
Aga Khan University Hospital, Karachi, Pakistan
Background: Large volume paracentesis (LVP) in pa-
tients with cirrhosis may lead to significant hemodynamic 
changes termed paracentesis-induced circulatory dysfunc-
tion (PICD). PICD is marked by increased renin, impaired 
renal function (IRF), and decreased serum sodium. Intra-
venous albumin is effectively used to prevent PICD and 
IRF. The exact dose of i.v. albumin, however, is not yet 
established.
Aim: To compare 25 g and 50 g of 25% i.v. albumin to pre-
vent IRF associated with PICD in patients with cirrhosis 
undergoing LVP.
Method: Case records of patients with cirrhosis who un-
derwent LVP from January 2008 to July 2010 were reviewed. 
Patients with spontaneous bacterial peritonitis, creatinine 
>1.5 mg/dL, hepatoma, coexisting malignancy, or paracen-
tesis of <5 L were excluded. Demographics, etiology, and 
laboratory parameters along with the amount of LVP and 
the dose of albumin received were noted. Moreover, serum 
creatinine and serum sodium at baseline and 1 week post 
paracentesis were recorded.
Result: Two-hundred and fourteen patients with cirrho-
sis underwent LVP during the study period. Among them, 
141 met the inclusion criteria and were included for analysis. 
We found that 110 patients received 25 g of i.v. albumin 
while 31 received 50 g of IV albumin after LVP. Mean age 
in both these groups were 54 ± 11 and 53 ± 10 years, respec-
tively. Hepatitis C was the predominant etiology which 
was found in 70% and 55% in 25 g and 50 g albumin group, 
respectively. More than 70% patients in both groups be-
longed to Child Turcot Pugh Class C. Mean ascitic fluid 
removed was 6.7 L in 25 g albumin group while 8.5 L in 
50 g albumin group. Serum creatinine at baseline and 
1 week post-LVP was 1.04 ± 0.02 and 1.07 ± 0.03 in the 25 g 
albumin group while 1.12 ± 0.04 and 1.41 ± 0.17 in 50 g 
albumin, respectively (P = 0.35). Similarly, serum sodium at 
baseline and 1 week post-LVP was 130.44 ± 3.5 and 129.62 ± 
4.1 in the low-dose albumin group, while 129.62 ± 5.6 and 
128.7 ± 6.0 in 50 g albumin (P = 0.14).
Conclusion: We conclude that 25 g of 25% i.v. albumin 
may be as effective as 50 g in preventing renal impairment 
after LVP in cirrhosis. The results of this study need further 
validation in a large prospective cohort.
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